Related references
Note: Only part of the references are listed.Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study
Aurelie Lenglet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
Sophie Liabeuf et al.
CLINICAL SCIENCE (2016)
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
Andrew C. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure
Cheng-Jui Lin et al.
PLOS ONE (2015)
Pharmacological Doses of Nicotinic Acid and Nicotinamide Are Independently Metabolized in Rats
Katsumi Shibata et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2014)
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase
Hiroshi Watanabe et al.
KIDNEY INTERNATIONAL (2013)
p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells
Chiao-Yin Sun et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
Aurelie Lenglet et al.
DRUGS IN R&D (2013)
N-Methylnicotinamide Is an Endogenous Probe for Evaluation of Drug-Drug Interactions Involving Multidrug and Toxin Extrusions (MATE1 and MATE2-K)
S. Ito et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Cellular Toxicity of Nicotinamide Metabolites
Boleslaw Rutkowski et al.
JOURNAL OF RENAL NUTRITION (2012)
Normal and Pathologic Concentrations of Uremic Toxins
Flore Duranton et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin-Angiotensin-Aldosterone System Associated Epithelial-to-Mesenchymal Transition
Chiao-Yin Sun et al.
PLOS ONE (2012)
Niacin and its metabolites: role of LC-MS/MS bioanalytical methods and update on clinical pharmacology. An overview
Ramesh Mullangi et al.
BIOMEDICAL CHROMATOGRAPHY (2011)
4-Pyridone-3-carboxamide-1-β-D-ribonucleoside Triphosphate (4PyTP), a Novel NAD+ Metabolite Accumulating in Erythrocytes of Uremic Children: A Biomarker for a Toxic NAD+ Analogue in Other Tissues?
Elena Synesiou et al.
TOXINS (2011)
Simultaneous determination of niacin and its metabolites-nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide-in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
Jaswanth Kumar Inamadugu et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
Simultaneous determination of nicotinic acid and its four metabolites in rat plasma using high performance liquid chromatography with tandem mass spectrometric detection (LC/MS/MS)
Malgorzata Szafarz et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Niacin Status, NAD Distribution and ADP-Ribose Metabolism
James B. Kirkland
CURRENT PHARMACEUTICAL DESIGN (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Nicotinamide metabolites accumulate in the tissues of uremic rats
Przemyslaw Rutkowski et al.
JOURNAL OF RENAL NUTRITION (2008)
What is new in uremic toxicity?
Raymond Vanholder et al.
PEDIATRIC NEPHROLOGY (2008)
Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure
Ewa M. Slominska et al.
PEDIATRIC NEPHROLOGY (2006)
Thrombocytopenia induced by nicotinamide in hemodialysis patients
JB Rottembourg et al.
KIDNEY INTERNATIONAL (2005)
Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure
N Eto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Chronic kidney disease as cause of cardiovascular morbidity and mortality
R Vanholder et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma
E Slominska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure
EA Carrey et al.
CLINICA CHIMICA ACTA (2003)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?
B Rutkowski et al.
KIDNEY INTERNATIONAL (2003)
Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure
EM Slominska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Share Paper
